Skip to content
Subscriber Only

Life Technology Told to Pay $52 Million in Promega Case

Life Technologies Corp. was told by a U.S. jury to pay $52 million for infringing patents owned by Promega Corp. related to genetic testing.

The federal jury in Madison, Wisconsin, also found that Life’s infringement of the patents was intentional, closely held Promega said in a statement. That means U.S. District Judge Barbara Crabb could increase the award by as much as three times the verdict.